Abstract
The continuing discovery and development of β-lactams as antibio-tics has had an unparalleled impact on the overall health and well-being of society. Recently, appropriately substituted cephalo-sporins were shown to be potent inhibitors of elastase1, suggesting a novel therapeutic role for the β-lactams in the control of emphysema and other degenerative diseases2,3. We have now solved and partially refined at atomic resolution the structure of a com-plex of porcine pancreatic elastase with the time-dependent irreversible inhibitor 3-acetoxymethyl-7-α-chloro-3-cephem-4-carboxylate-l,l-dioxide tert-butyl ester (I), the most potent of the β-lactam elastase inhibitors yet reported1. (Porcine pancreatic elastase is a close relative of the desired drug target, human polymorphonuclear leukocyte elastase.) A mechanism of action is presented, based on the structure and on biochemical evidence (T.-Y.L. et al., in preparation), which clarifies the operational similarities and differences between β-lactam elastase inhibitors and antibiotics. Features of the reaction include the expulsion of a leaving group at the cephalosporin 3′position and the formation of two covalent bonds with the active site of porcine pancreatic elastase at residues Ser 195 and His 57.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Doherty, J. B. et al. Nature 322, 192–194 (1986). 2. Janoff, A. A. Rev. Med. 36, 207–216 (1985). 3. Stein, R. L., Trainor, D. A. & Wildonger, R. A. Rep. med. Chem. 20, 237–246 (1985). 4. Brown, A. G. / antimicrob. Chemother. 10, 365–372 (1982). 5. Pratt, R. F. & Faraci, W. S. /. Am. chem. Soc. 108, 5328–5333 (1986). 6. Knowles, J. R. Ace. Chem. Res. 18, 97–104 (1985). 7. Boyd, D. B. J. mednl. Chem. 27, 63–66 (1984). 8. Kraut, J. A. Rev. Biochem. 46, 331–358 (1977). 9. Cohen, G. H., Silverton, E. W. & Davies, D. R. /. molec. Biol. 148, 449–479 (1981). 10. Schecter, I. & Berger, A. Biochem. biophys. Res. Commun. 27, 157–162 (1967). 11. James, M. N. G., Sielecki, A. R., Brayer, G. D., Delbaere, L. T. J. & Bauer, C.–A. /. molec. Biol. 144, 43–88 (1980). 12. Cohen, N. C. J. mednl. Chem. 26, 259–264 (1983). 13. Page, M. I. Ace. Chem. Res. 17, 144–151 (1984). 14. Lamotte–Brasseur, J. Dive, G. & Ghuysen, J.–M. Eur. J. med. Chem. 19, 319–330 (1984). 15. Waxman, D. J. & Strominger, J. L. A. Rev. Biochem. 52, 825–869 (1983). 16. Hendrickson, W. A. & Konnert, J. H. Computing in Crystallography (eds Diamond, R., Ramaseshan, S. & Venkatesan, K.) 13.01–13.23 (Indian Academy of Sciences, Bangalore, 1980). 17. Sielecki, A. R. et al. J. molec. Biol. 134, 781–804 (1979). 18. Sawyer, L. et al. J. molec. Biol. 118, 137–208 (1975). 19. McPherson, A. Preparation and Analysis of Protein Crystals (Wiley, New York, 1982). 20. Navia, M. A., Springer, J. P., Poe, M., Boger, J. & Hoogsteen, K. J. biol. Chem. 259, 12714–12717 (1984). 21. Sparks, R. A. Computational Crystallography (ed. Sayre, D.) 1–18 (Clarendon Press Oxford 1982). 22. North, A. C. T., Phillips, D. C. & Mathews, F. S. Ada crystallogr. A 24, 351–359 (1967). 23. Saper, M. thesis, Rice Univ., Houston (1983). 24. Steigemann, W. thesis, Technische Universitat, Munchen (1974). 25. Gund, P., Andose, J. D., Rhodes, J. B. & Smith, G. M. Science 208, 1425–1431 (1980). 26. Jones, T. A. Computational Crystallography (ed. Sayre, D.) 303–317 (Clarendon Press, Oxford, 1982). 27. Bush, B. L. Computers Chem. 8, 1–11 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Navia, M., Springer, J., Lin, TY. et al. Crystallographie study of a β-lactam inhibitor complex with elastase at 1.84 Å resolution. Nature 327, 79–82 (1987). https://doi.org/10.1038/327079a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/327079a0
This article is cited by
-
Molecular recognition: Models for drug design
Experientia (1991)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.